On the other hand, the loss of SMAD4, a transcription factor involved in the signaling of the TGF-β superfamily, promotes tumor progression and SMAD4-deficient CRC, and is linked to short survival for patients [122]. This evidence concerns the gene TGFB1 and neoplasm.